Access to drugs is going to be unsustainable in the future as the EU faces an ageing population, and the only saving grace will be increasing generic medicines volume, a patient access meeting has been told.
Speaking at the event organised by the European Generic medicines Association, Professor Steven Simoens from Katholieke Universiteit Leuven said “savings of an additional €16 billion per annum could be achieved by increasing generic medicines volume in key areas related to the ageing population”.
The problem Europe faces has two sides – an ageing population and a falling birth rate. It is anticipated that in the near future fewer workers will be paying larger healthcare bills to treat age-related diseases in an increasing number of elderly patients.
No comments:
Post a Comment